SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19

Summary

This protocol provides access to eculizumab treatment for participants with severe COVID-19.

Timeline

Start

—

Primary completion

—

Completion

—

Publications

• Burwick RM, Dellapiana G, Newman RA, Smithson SD, Naqvi M, Williams J 3rd, Wong MS, Bautista M, Gaden A, Kazani SD, Dunn DA, Ma MH, Mitter S, Monteleone JPR, Ortiz SR, Ghandehari S, Merin N, Zakowski MI, Karumanchi SA. Complement blockade with eculizumab for treatment of severe Coronavirus Disease 2019 in pregnancy: A case series. Am J Reprod Immunol. 2022 Aug;88(2):e13559. doi: 10.1111/aji.13559. Epub 2022 May 12.

Drugs

Indications